These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 6151651)

  • 41. [Influence of personality factors on the success of psychopharmacotherapy].
    Rüger U
    Psychiatr Prax; 1985 Jan; 12(1):5-7. PubMed ID: 2858900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1).
    McDaniel KD
    Clin Pediatr (Phila); 1986 Feb; 25(2):65-71. PubMed ID: 2417773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adderall and other drugs for attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1994 Nov; 36(936):109-10. PubMed ID: 7968783
    [No Abstract]   [Full Text] [Related]  

  • 46. New psychoactive drugs.
    Murray JB
    Genet Soc Gen Psychol Monogr; 1985 Nov; 111(4):429-53. PubMed ID: 2873081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychotropic medication patterns among youth in foster care.
    Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
    Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder.
    Young J
    Adolesc Med State Art Rev; 2008 Aug; 19(2):216-28, vii. PubMed ID: 18822828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategies for the prescription of psychotropic drugs with black box warnings.
    Stevens JR; Jarrahzadeh T; Brendel RW; Stern TA
    Psychosomatics; 2014; 55(2):123-33. PubMed ID: 24360525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of psychotropic drugs in children].
    Purper-Ouakil D
    Arch Pediatr; 2008 Dec; 15(12):1834-6. PubMed ID: 18995997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Unwanted drug effects of psychotropic drugs in neurologic practice].
    Schmidt LG; Schüssler G; Linden M; Müller-Oerlinghausen B
    Nervenarzt; 1985 Jan; 56(1):19-24. PubMed ID: 2858064
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacotherapy of attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical management of Tourette's syndrome and associated disorders.
    Sandor P
    Can J Psychiatry; 1995 Dec; 40(10):577-83. PubMed ID: 8681254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bipolar disorders--how to recognize and treat them].
    Grunze H; Sasse J; Forsthoff A; Bauer M
    MMW Fortschr Med; 2004 May; 146 Spec No 2():4-6, 8. PubMed ID: 15376694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attention deficit hyperactivity disorder. Epidemiologic, pathophysiologic, diagnostic and treatment perspectives.
    Al-Ghamdy YS; Qureshi NA
    Saudi Med J; 2001 Aug; 22(8):666-73. PubMed ID: 11573110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacologic treatment of manic and depressive illness.
    Ostow M
    Compr Ther; 1985 Jul; 11(7):24-30. PubMed ID: 2863029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Geriatric psychopharmacology. Management of late-life depression and the noncognitive behavioral disturbances of Alzheimer's disease.
    Raskind MA
    Psychiatr Clin North Am; 1993 Dec; 16(4):815-27. PubMed ID: 7906030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The challenge of childhood depression and ADHD.
    Manas-Lammers LA
    JAAPA; 2002 Dec; 15(12):31-4, 39-40, 56. PubMed ID: 12555737
    [No Abstract]   [Full Text] [Related]  

  • 59. Concurrent psychotropic medication has no negative influence on the outcome of electroconvulsive therapy.
    O'Brien PD; Berrios GE
    Encephale; 1993; 19(4):347-9. PubMed ID: 7903929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of hyperactivity in children with pervasive developmental disorders.
    Scahill L; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.